Eton Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
Eton Pharmaceuticals, Inc.‘s stocks are currently a part of 23 hedge funds’ portfolios, which represents 14.68% of the total amount of its stocks outstanding. This makes up a total of 3.72M shares of Eton Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -37.29% or -2.21M shares fewer. As for the holding position changes, 17.39% (4) of current hedge fund investors increased the number of shares held, 21.74% (5) of current holders sold a part of the shares held, and 17.39% (4) closed the holdings completely. 6 hedge funds are new holders of Eton Pharmaceuticals, Inc. stock in Q1 2023, it is 26.09% of total holders.
Hedge funds holding Eton Pharmaceuticals (Q4 2018 – Q1 2023)
| Q4 2018 | 12 |
|---|---|
| Q1 2019 | 12 |
| Q2 2019 | 10 |
| Q3 2019 | 14 |
| Q4 2019 | 13 |
| Q1 2020 | 17 |
| Q2 2020 | 41 |
| Q3 2020 | 38 |
| Q4 2020 | 46 |
| Q1 2021 | 49 |
| Q2 2021 | 45 |
| Q3 2021 | 36 |
| Q4 2021 | 31 |
| Q1 2022 | 28 |
| Q2 2022 | 28 |
| Q3 2022 | 30 |
| Q4 2022 | 31 |
| Q1 2023 | 23 |
Hedge funds changes in Eton Pharmaceuticals positions (Q4 2018 – Q1 2023)
| Q4 2018 | 12 | 0 | 0 | 0 | 0 |
|---|---|---|---|---|---|
| Q1 2019 | 3 | 5 | 1 | 3 | 0 |
| Q2 2019 | 1 | 6 | 1 | 3 | -1 |
| Q3 2019 | 5 | 7 | 1 | 1 | 0 |
| Q4 2019 | 3 | 6 | 1 | 4 | -1 |
| Q1 2020 | 5 | 7 | 4 | 1 | 0 |
| Q2 2020 | 26 | 9 | 5 | 2 | -1 |
| Q3 2020 | 5 | 10 | 17 | 8 | -2 |
| Q4 2020 | 10 | 26 | 6 | 2 | 2 |
| Q1 2021 | 6 | 15 | 18 | 3 | 7 |
| Q2 2021 | 16 | 6 | 17 | 20 | -14 |
| Q3 2021 | 8 | 10 | 10 | 17 | -9 |
| Q4 2021 | 6 | 7 | 11 | 11 | -4 |
| Q1 2022 | 6 | 7 | 9 | 9 | -3 |
| Q2 2022 | 5 | 5 | 10 | 4 | 4 |
| Q3 2022 | 3 | 8 | 7 | 2 | 10 |
| Q4 2022 | 7 | 6 | 6 | 6 | 6 |
| Q1 2023 | 6 | 4 | 5 | 4 | 4 |
Hedge funds changes in Eton Pharmaceuticals stock options (Q4 2018 – Q1 2023)
| Q4 2018 | 0 | 0 |
|---|---|---|
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 0 | 0 |
| Q1 2021 | 73,000 | 54,000 |
| Q2 2021 | 750,000 | 423,000 |
| Q3 2021 | 637,000 | 331,000 |
| Q4 2021 | 444,000 | 215,000 |
| Q1 2022 | 1,606,000 | 148,000 |
| Q2 2022 | 847,000 | 6,000 |
| Q3 2022 | 291,000 | 0 |
| Q4 2022 | 289,440 | 0 |
| Q1 2023 | 50,469,000 | 0 |